Breaking News
Sort by:
Top Post
Global Fund Results Report Reveals COVID-19 Devastating Impact on HIV, TB and Malaria Programs
The COVID-19 pandemic had a devastating impact on the fight against HIV, TB and malaria […]
Swiss Medtech Bloom Diagnostics Company Opens its First Flagship Store in Zurich
Swiss medtech company Bloom Diagnostics has, today, opened its first-ever flagship store at a busy […]
Additional £5.4 Billion for NHS Covid Response Over Next Six Months
The NHS will receive an extra £5.4 billion over the next six months to support […]
New Study to Test Third COVID-19 Vaccine for People with Weakened Immune Systems
A new clinical trial to determine whether a third dose of vaccine will improve the […]
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older
Pfizer Inc.and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) approved […]
Government Launches First UK-wide Antibody Surveillance Programme
Thousands of adults a day will be given free access to antibody tests through a […]
First Monoclonal Antibody Treatment for COVID-19 Approved for Use in the UK
Following on from a thorough review of the evidence carried out by the MHRA, and […]
Therapeutic Solutions International Identifies and Files Patent on Novel Mechanism of Action of Its FDA Phase III Cleared JadiCell™ Treatment of COVID-19 and Delta Variant
Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today novel data and filing of a […]
Royal Wolverhampton NHS Trust (RWT) and Babylon bring digital-first, value-based healthcare to over 55,000 people across Wolverhampton
Royal Wolverhampton NHS Trust (RWT) and Babylon today announced they have extended their partnership to bring […]
NHS Comment on Milestone of 75% of All Adults Double-Jabbed in England
NHS comment as the latest vaccine statistics published today show that 75% of people aged […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more